Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaping Li

Showing results (51-60 of 191) with videos related to

Pageof 20
Sort By:
Cancer Communications (London, England)|May 17, 2018
Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysisWang Yao, Yuqi Meng, Mingjian Lu, et al.
Oncotarget|June 21, 2016
Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinomaYu Wang, Wei Cui, Wenzhe Fan, et al.
Cardiovascular and Interventional Radiology|March 21, 2013
Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgeryJunxing Chen, Zhijun Yao, Shaopeng Qiu, et al.
Translational Oncology|December 8, 2022
Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular CarcinomaXiaokai Zhang, Jie Wen, Guixiong Zhang, et al.
Frontiers in Cell and Developmental Biology|May 16, 2022
Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular CarcinomaGuixiong Zhang, Wenzhe Fan, Hongyu Wang, et al.
Oncology Research and Treatment|February 3, 2018
Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor ResectionWei Cui, Wenzhe Fan, Mingjian Lu, et al.
Anti-Cancer Drugs|February 2, 2023
Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapyJiaping Li, Qianyi Lu, Hanxing Zhou, et al.
Biomaterials Advances|June 30, 2026
Adding beta-tricalcium phosphate ceramic to additive manufactured 3D porous Ti6Al4V scaffolds enhances osteogenic activity of human mesenchymal stromal cells in vitroDavid C Koper, Jiaping Li, Peter A W H Kessler, et al.
Cancer Management and Research|June 12, 2020
Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationHongyu Wang, Chuyang Lin, Wenzhe Fan, et al.
Journal of Cancer Research and Therapeutics|June 1, 2020
Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolizationHongyu Wang, Bin Li, Yu Wang, et al.
Pageof 20

Showing results (51-60 of 191) with videos related to

Sort By:
Pageof 20
Cancer Communications (London, England)|May 17, 2018
Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysisWang Yao, Yuqi Meng, Mingjian Lu, et al.
Oncotarget|June 21, 2016
Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinomaYu Wang, Wei Cui, Wenzhe Fan, et al.
Cardiovascular and Interventional Radiology|March 21, 2013
Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgeryJunxing Chen, Zhijun Yao, Shaopeng Qiu, et al.
Translational Oncology|December 8, 2022
Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular CarcinomaXiaokai Zhang, Jie Wen, Guixiong Zhang, et al.
Frontiers in Cell and Developmental Biology|May 16, 2022
Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular CarcinomaGuixiong Zhang, Wenzhe Fan, Hongyu Wang, et al.
Oncology Research and Treatment|February 3, 2018
Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor ResectionWei Cui, Wenzhe Fan, Mingjian Lu, et al.
Anti-Cancer Drugs|February 2, 2023
Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapyJiaping Li, Qianyi Lu, Hanxing Zhou, et al.
Biomaterials Advances|June 30, 2026
Adding beta-tricalcium phosphate ceramic to additive manufactured 3D porous Ti6Al4V scaffolds enhances osteogenic activity of human mesenchymal stromal cells in vitroDavid C Koper, Jiaping Li, Peter A W H Kessler, et al.
Cancer Management and Research|June 12, 2020
Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationHongyu Wang, Chuyang Lin, Wenzhe Fan, et al.
Journal of Cancer Research and Therapeutics|June 1, 2020
Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolizationHongyu Wang, Bin Li, Yu Wang, et al.
Pageof 20